Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial

BACKGROUND: Cancer trials involving multiple treatment lines substantially increase our understanding of therapeutic strategies. However, even when the primary end-point of these studies is progression-free survival (PFS), their statistical analysis usually focuses on each line separately, or does n...

Descripción completa

Detalles Bibliográficos
Autores principales: Petracci, Elisabetta, Scarpi, Emanuela, Passardi, Alessandro, Biggeri, Annibale, Milandri, Carlo, Vecchia, Stefano, Gelsomino, Fabio, Tassinari, Davide, Tamberi, Stefano, Bernardini, Ilaria, Accettura, Caterina, Frassineti, Giovanni Luca, Amadori, Dino, Nanni, Oriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378711/
https://www.ncbi.nlm.nih.gov/pubmed/32754229
http://dx.doi.org/10.1177/1758835920937427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378711/
https://www.ncbi.nlm.nih.gov/pubmed/32754229
http://dx.doi.org/10.1177/1758835920937427

Ejemplares similares